Search Immortality Topics:

Page 521«..1020..520521522523..530540..»


Category Archives: Stem Cell Therapy

Stem Cell Ttreatment Financing – Video

http://www.StemCellTreatment.org Looking for stem cell treatment financing? At the American Stem Cell

Visit link:
Stem Cell Ttreatment Financing - Video

Posted in Stem Cell Therapy | Comments Off on Stem Cell Ttreatment Financing – Video

Adult Stem Cell Research – Video

http://www.StemCellTreatment.org Thanks to adult stem cell research, stem cell therapy is going mainstream. Many celebrities and professional athletes are getting adult stem cell treatment and helping to open the doors for eventual full authorization here in the United States.

Original post:
Adult Stem Cell Research - Video

Posted in Stem Cell Therapy | Comments Off on Adult Stem Cell Research – Video

Stem Cell Treatment Parkinson – Video

http://www.StemCellTreatment.org Testimonial of a patient with Parkinson's disease. Bill Stanziano received a Stem Cell Treatment for Parkinson at American Cellular

Go here to read the rest:
Stem Cell Treatment Parkinson - Video

Posted in Stem Cell Therapy | Comments Off on Stem Cell Treatment Parkinson – Video

Amazing Stem Cell Therapy Results | Before

This is a compilation of a commercial teaser and two separate stories that Local 6 Orlando did on Val-U-Vet and Stem Cell Therapy. Go to http://www.valuvet.com for more info.

More here:
Amazing Stem Cell Therapy Results | Before

Posted in Stem Cell Therapy | Comments Off on Amazing Stem Cell Therapy Results | Before

CIRM’s Thomas Blogs on Geron and the Stem Cell Business


The chairman of the $3 billion California stem cell agency has made his second entry into the blogosphere, this time adding a bit more on Geron's abandonment of what would have been its historic hESC clinical trial.

Jonathan Thomas, a Los Angeles bond financier, wrote yesterday on the CIRM research blog, which has recently been the site of more spritely and relevant items.

Geron's action has particular relevance for CIRM, which awarded the company a $25 million loan last May to help with the clinical trial.

Thomas said CIRM's "immediate concern" when officials heard the surprise news was for the patients and the families involved in the trials. Thomas continued,

"However, Geron is a business. The company decided that their cancer therapies were farther along than the stem cell trial and when they held the stem cell program against the prism of economic reality they made a business decision to end the trial."

Thomas also minimized the importance of Geron to CIRM. He said,

"CIRM’s award to Geron was just one of the 44 projects in 26 disease areas that are in various stages of working toward clinical trials."

It was a somewhat different story last May when former stem cell agency chairman Robert Klein said in a widely distributed CIRM news release,

"Supporting the Geron trial is a landmark step for CIRM."

Regardless of the spin on Geron from either CIRM or others who are more skeptical, Thomas' entry into the world of electronic media is to be applauded as is what appears to be a new direction in the research blog.

The CIRM blog is now newsier, more lively with more variety and more voices. All of which should redound, albeit modestly, to CIRM efforts to improve its communications with the public and opinion makers. The difficult thing about blogs, however, is the time and effort required to sustain them, and the task could be something of a communications test for CIRM. Blogs constantly need to be fed. Indeed, blogs are voracious, sort of like the carnivorous plant called Seymour in "The Little Shop of Horrors." As many of you may recall, Seymour had a simple but insistent refrain, "Feed me, feed me, feed me."

Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cell Therapy, Stem Cells | Comments Off on CIRM’s Thomas Blogs on Geron and the Stem Cell Business

CIRM's Thomas Blogs on Geron and the Stem Cell Business


The chairman of the $3 billion California stem cell agency has made his second entry into the blogosphere, this time adding a bit more on Geron's abandonment of what would have been its historic hESC clinical trial.

Jonathan Thomas, a Los Angeles bond financier, wrote yesterday on the CIRM research blog, which has recently been the site of more spritely and relevant items.

Geron's action has particular relevance for CIRM, which awarded the company a $25 million loan last May to help with the clinical trial.

Thomas said CIRM's "immediate concern" when officials heard the surprise news was for the patients and the families involved in the trials. Thomas continued,

"However, Geron is a business. The company decided that their cancer therapies were farther along than the stem cell trial and when they held the stem cell program against the prism of economic reality they made a business decision to end the trial."

Thomas also minimized the importance of Geron to CIRM. He said,

"CIRM’s award to Geron was just one of the 44 projects in 26 disease areas that are in various stages of working toward clinical trials."

It was a somewhat different story last May when former stem cell agency chairman Robert Klein said in a widely distributed CIRM news release,

"Supporting the Geron trial is a landmark step for CIRM."

Regardless of the spin on Geron from either CIRM or others who are more skeptical, Thomas' entry into the world of electronic media is to be applauded as is what appears to be a new direction in the research blog.

The CIRM blog is now newsier, more lively with more variety and more voices. All of which should redound, albeit modestly, to CIRM efforts to improve its communications with the public and opinion makers. The difficult thing about blogs, however, is the time and effort required to sustain them, and the task could be something of a communications test for CIRM. Blogs constantly need to be fed. Indeed, blogs are voracious, sort of like the carnivorous plant called Seymour in "The Little Shop of Horrors." As many of you may recall, Seymour had a simple but insistent refrain, "Feed me, feed me, feed me."

Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cell Therapy, Stem Cells | Comments Off on CIRM's Thomas Blogs on Geron and the Stem Cell Business